Searched for
PHARMACEUTICAL COMPANY REGULATIONS
'We unleashed the beast': the world's fears and hopes about AIGlobal discussions are occurring about regulating artificial intelligence development. People in various countries share fears and hopes fo...15 Sep, 2026, 01.42 PM IST- India’s food safety rules are giving restaurants heartburn: It’s the process, not just the productIndia’s food safety regime has shifted from testing adulteration in the final product to policing the processes that prevent it. Restaurant...11 Sep, 2026, 11.48 PM IST
- Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observationsAlembic Pharmaceuticals has reported that its Vadodara facility passed the recent inspection by the United States Food and Drug Administrat...11 Sep, 2026, 02.18 PM IST
- Graph AI raises $13.3 million from Insight Partners, Bessemer to scale AI-native patient-safety platformThe new funds will be used to expand across the US and Europe, as the startup looks to change the pharmacovigilance industry’s services-hea...11 Sep, 2026, 10.47 AM IST
- Beyond Los Angeles and Rotterdam: Can Durban, Rio de Janeiro drive India’s next export boom?The South-South trade has crossed $7 trillion, opening new opportunities for Indian exporters across Africa, ASEAN, the Gulf, and Latin Ame...10 Sep, 2026, 07.48 AM IST
- Prasol Chemicals IPO Day 2: GMP, subscription status. Should you subscribe?Prasol Chemicals IPO saw 72% subscription by Day 2, with retail investors showing strong interest. The grey market premium remains modest a...09 Sep, 2026, 06.49 PM IST
- Prasol Chemicals IPO opens for bidding. Check GMP and other key detailsThe Prasol Chemicals IPO opened for subscription on September 8 and will remain open until September 10. The Rs 500 crore issue comprises a...08 Sep, 2026, 09.54 AM IST
- Pharma sector must attract more investment in clinical trials, R&D: Piyush GoyalPiyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...06 Sep, 2026, 11.21 PM IST
- Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...04 Sep, 2026, 07.01 PM IST
- After Adani, Tata feels the heat: Indian firms under fire in Kenya?Kenya’s dispute with Tata Chemicals has revived concerns about Indian businesses in the country after Adani’s exit. But Kenya continues to ...04 Sep, 2026, 05.44 PM IST
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe Indian market was under pressure on Thursday, particularly at the index level. Rising crude-oil prices are an obvious concern, but dome...04 Sep, 2026, 11.31 AM IST
- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...04 Sep, 2026, 12.51 AM IST
- Daiichi-Ranbaxy case: Delhi HC orders forensic audit into transactions of Fortis, Singh brothersThe Delhi High Court has appointed a forensic auditor to examine transactions. This audit aims to trace the dissipation of Fortis Healthcar...01 Sep, 2026, 09.24 AM IST
- Global buyers care less about where SaaS is built, more about what it delivers: SmartWinnr CEOSmartWinnr CEO Anindita Banik on why India’s SaaS companies are increasingly being judged on product quality and performance, rather than t...31 Aug, 2026, 10.52 AM IST
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...28 Aug, 2026, 11.42 PM IST
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...27 Aug, 2026, 07.17 PM IST
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...26 Aug, 2026, 06.21 PM IST
Load More
